Patent EP 2 819 699 B1 relates to controlled release compositions and their method of use, and to low viscosity controlled release compositions for use in the treatment of mastitis in lactating animals.
Brief outline of the case
The OD decided that the new MR filed in opposition was infringing Art 123(2).